nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycerol Phenylbutyrate—Decreased appetite—Cabazitaxel—prostate cancer	0.00314	0.00556	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Degarelix—prostate cancer	0.00314	0.00555	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Cabazitaxel—prostate cancer	0.00312	0.00552	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Cabazitaxel—prostate cancer	0.00311	0.00552	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Nilutamide—prostate cancer	0.00308	0.00545	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Estramustine—prostate cancer	0.00308	0.00545	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Flutamide—prostate cancer	0.00307	0.00543	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Estrone—prostate cancer	0.00306	0.00541	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Estramustine—prostate cancer	0.00305	0.0054	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Estramustine—prostate cancer	0.00305	0.0054	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Bicalutamide—prostate cancer	0.00304	0.00538	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Degarelix—prostate cancer	0.00303	0.00537	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Estramustine—prostate cancer	0.00303	0.00537	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Abiraterone—prostate cancer	0.00299	0.00529	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Abiraterone—prostate cancer	0.00296	0.00525	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Abiraterone—prostate cancer	0.00296	0.00524	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Mitoxantrone—prostate cancer	0.00296	0.00524	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Cabazitaxel—prostate cancer	0.00295	0.00523	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Estrone—prostate cancer	0.00294	0.0052	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Nilutamide—prostate cancer	0.00294	0.0052	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Flutamide—prostate cancer	0.00292	0.00518	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Estrone—prostate cancer	0.00291	0.00516	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Estrone—prostate cancer	0.00291	0.00516	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Estrone—prostate cancer	0.0029	0.00513	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Estradiol valerate/Dienogest—prostate cancer	0.00289	0.00512	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Estradiol—prostate cancer	0.00288	0.0051	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Estramustine—prostate cancer	0.00287	0.00509	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Cabazitaxel—prostate cancer	0.00286	0.00506	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Nilutamide—prostate cancer	0.00284	0.00503	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Flutamide—prostate cancer	0.00283	0.005	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Degarelix—prostate cancer	0.00275	0.00487	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Estrone—prostate cancer	0.00275	0.00486	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Nilutamide—prostate cancer	0.00273	0.00483	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Bicalutamide—prostate cancer	0.00273	0.00483	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Flutamide—prostate cancer	0.00272	0.00481	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Nilutamide—prostate cancer	0.00271	0.00479	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Nilutamide—prostate cancer	0.0027	0.00479	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Flutamide—prostate cancer	0.00269	0.00477	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Bicalutamide—prostate cancer	0.00269	0.00477	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Flutamide—prostate cancer	0.00269	0.00477	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Nilutamide—prostate cancer	0.00269	0.00476	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Flutamide—prostate cancer	0.00268	0.00474	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Bicalutamide—prostate cancer	0.00268	0.00474	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Bicalutamide—prostate cancer	0.00267	0.00473	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.00267	0.00472	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Goserelin—prostate cancer	0.00264	0.00468	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Degarelix—prostate cancer	0.00262	0.00465	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Conjugated Estrogens—prostate cancer	0.00262	0.00463	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Goserelin—prostate cancer	0.0026	0.00461	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Cabazitaxel—prostate cancer	0.00259	0.00459	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Conjugated Estrogens—prostate cancer	0.00258	0.00457	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Ethinyl Estradiol—prostate cancer	0.00257	0.00455	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.00256	0.00454	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Nilutamide—prostate cancer	0.00255	0.00452	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Estradiol valerate/Dienogest—prostate cancer	0.00254	0.0045	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.00254	0.0045	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Flutamide—prostate cancer	0.00254	0.0045	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Degarelix—prostate cancer	0.00254	0.00449	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Bicalutamide—prostate cancer	0.00253	0.00449	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Estradiol valerate/Dienogest—prostate cancer	0.00253	0.00447	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Cabazitaxel—prostate cancer	0.00247	0.00438	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Bicalutamide—prostate cancer	0.00245	0.00434	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Degarelix—prostate cancer	0.00244	0.00432	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Degarelix—prostate cancer	0.00242	0.00428	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Degarelix—prostate cancer	0.00242	0.00428	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Degarelix—prostate cancer	0.0024	0.00425	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.0024	0.00424	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Cabazitaxel—prostate cancer	0.00239	0.00423	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Cabazitaxel—prostate cancer	0.0023	0.00407	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Degarelix—prostate cancer	0.00228	0.00403	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Cabazitaxel—prostate cancer	0.00226	0.00401	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Ethinyl Estradiol—prostate cancer	0.00226	0.004	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Ethinyl Estradiol—prostate cancer	0.00226	0.004	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Bicalutamide—prostate cancer	0.00222	0.00394	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Cabazitaxel—prostate cancer	0.00215	0.0038	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Ethinyl Estradiol—prostate cancer	0.00214	0.00379	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Bicalutamide—prostate cancer	0.00212	0.00375	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Goserelin—prostate cancer	0.00211	0.00374	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Conjugated Estrogens—prostate cancer	0.00209	0.00371	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Estradiol—prostate cancer	0.00209	0.00371	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Ethinyl Estradiol—prostate cancer	0.00207	0.00367	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Estradiol—prostate cancer	0.00206	0.00365	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Bicalutamide—prostate cancer	0.00205	0.00363	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Docetaxel—prostate cancer	0.00205	0.00362	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Capecitabine—prostate cancer	0.00198	0.00351	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Bicalutamide—prostate cancer	0.00197	0.00349	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Bicalutamide—prostate cancer	0.00195	0.00346	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Bicalutamide—prostate cancer	0.00195	0.00346	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Bicalutamide—prostate cancer	0.00194	0.00344	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Goserelin—prostate cancer	0.0019	0.00336	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Conjugated Estrogens—prostate cancer	0.00188	0.00333	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Ethinyl Estradiol—prostate cancer	0.00188	0.00333	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Goserelin—prostate cancer	0.00187	0.00332	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Goserelin—prostate cancer	0.00186	0.00329	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Conjugated Estrogens—prostate cancer	0.00186	0.00329	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.00184	0.00326	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Conjugated Estrogens—prostate cancer	0.00184	0.00326	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Bicalutamide—prostate cancer	0.00184	0.00326	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Capecitabine—prostate cancer	0.0018	0.00318	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.00179	0.00317	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Goserelin—prostate cancer	0.00176	0.00312	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.00175	0.00309	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Ethinyl Estradiol—prostate cancer	0.00173	0.00307	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Goserelin—prostate cancer	0.0017	0.00302	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Conjugated Estrogens—prostate cancer	0.00169	0.00299	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Estradiol—prostate cancer	0.00168	0.00297	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Ethinyl Estradiol—prostate cancer	0.00167	0.00295	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Ethinyl Estradiol—prostate cancer	0.00165	0.00292	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00165	0.00292	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Ethinyl Estradiol—prostate cancer	0.00164	0.00291	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Ethinyl Estradiol—prostate cancer	0.00156	0.00276	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Goserelin—prostate cancer	0.00155	0.00274	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Conjugated Estrogens—prostate cancer	0.00153	0.00271	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Estradiol—prostate cancer	0.0015	0.00266	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Estradiol—prostate cancer	0.00149	0.00263	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Estradiol—prostate cancer	0.00148	0.00261	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Goserelin—prostate cancer	0.00148	0.00261	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Estradiol—prostate cancer	0.00147	0.00261	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Conjugated Estrogens—prostate cancer	0.00146	0.00259	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Goserelin—prostate cancer	0.00143	0.00252	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Conjugated Estrogens—prostate cancer	0.00141	0.0025	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Mitoxantrone—prostate cancer	0.0014	0.00248	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Estradiol—prostate cancer	0.0014	0.00247	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Mitoxantrone—prostate cancer	0.00138	0.00245	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Epirubicin—prostate cancer	0.00138	0.00244	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Mitoxantrone—prostate cancer	0.00137	0.00243	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Goserelin—prostate cancer	0.00137	0.00243	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Goserelin—prostate cancer	0.00136	0.00241	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Goserelin—prostate cancer	0.00136	0.0024	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Conjugated Estrogens—prostate cancer	0.00136	0.0024	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Estradiol—prostate cancer	0.00135	0.00239	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Goserelin—prostate cancer	0.00135	0.00239	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Docetaxel—prostate cancer	0.00135	0.00239	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Conjugated Estrogens—prostate cancer	0.00135	0.00238	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Conjugated Estrogens—prostate cancer	0.00135	0.00238	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Conjugated Estrogens—prostate cancer	0.00134	0.00237	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Capecitabine—prostate cancer	0.00131	0.00231	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.0013	0.00231	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Capecitabine—prostate cancer	0.00129	0.00228	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	0.00128	0.00295	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Goserelin—prostate cancer	0.00128	0.00227	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SULT1E1—prostate cancer	0.00128	0.00294	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SRD5A1—prostate cancer	0.00128	0.00294	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain upper—Doxorubicin—prostate cancer	0.00128	0.00226	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Conjugated Estrogens—prostate cancer	0.00127	0.00225	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Mitoxantrone—prostate cancer	0.00126	0.00223	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GRPR—prostate cancer	0.00124	0.00286	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	0.00124	0.00286	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Estradiol—prostate cancer	0.00123	0.00217	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	0.00122	0.00281	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HSD17B3—prostate cancer	0.00122	0.0028	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ACSL4—prostate cancer	0.00122	0.0028	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	0.00121	0.00277	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL17RD—prostate cancer	0.0012	0.00276	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—UMPS—prostate cancer	0.00117	0.00269	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PHGDH—prostate cancer	0.00117	0.00269	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ARG2—prostate cancer	0.00117	0.00269	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Estradiol—prostate cancer	0.00117	0.00207	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	0.00116	0.00268	CbGpPWpGaD
Glycerol Phenylbutyrate—Malnutrition—Prednisone—prostate cancer	0.00116	0.00206	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Etoposide—prostate cancer	0.00115	0.00204	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—LDHB—prostate cancer	0.00115	0.00264	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Etoposide—prostate cancer	0.00114	0.00202	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Mitoxantrone—prostate cancer	0.00114	0.00202	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Etoposide—prostate cancer	0.00114	0.00202	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Estradiol—prostate cancer	0.00113	0.002	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP3A5—prostate cancer	0.00113	0.00259	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—GSTO1—prostate cancer	0.0011	0.00254	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Mitoxantrone—prostate cancer	0.00109	0.00193	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PDHA1—prostate cancer	0.00109	0.0025	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—TCN2—prostate cancer	0.00109	0.0025	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—UCP3—prostate cancer	0.00109	0.0025	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTA3—prostate cancer	0.00109	0.0025	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Estradiol—prostate cancer	0.00109	0.00192	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Etoposide—prostate cancer	0.00108	0.00192	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Docetaxel—prostate cancer	0.00108	0.00191	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Estradiol—prostate cancer	0.00108	0.00191	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Estradiol—prostate cancer	0.00108	0.00191	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Estradiol—prostate cancer	0.00107	0.0019	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—WNT4—prostate cancer	0.00107	0.00246	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—JUP—prostate cancer	0.00107	0.00246	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—LRP2—prostate cancer	0.00106	0.00243	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Etoposide—prostate cancer	0.00105	0.00185	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Capecitabine—prostate cancer	0.00105	0.00185	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—RPL10—prostate cancer	0.00104	0.00239	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—P4HB—prostate cancer	0.00104	0.00239	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—EIF2AK2—prostate cancer	0.00104	0.00239	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC22A3—prostate cancer	0.00104	0.00238	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HSD3B1—prostate cancer	0.00104	0.00238	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RALBP1—prostate cancer	0.00102	0.00234	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MC2R—prostate cancer	0.00102	0.00234	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HIST1H2BG—prostate cancer	0.00102	0.00234	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Estradiol—prostate cancer	0.00102	0.0018	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Mitoxantrone—prostate cancer	0.00101	0.00179	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—LPL—prostate cancer	0.00101	0.00231	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Mitoxantrone—prostate cancer	0.001	0.00178	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Mitoxantrone—prostate cancer	0.001	0.00178	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Mitoxantrone—prostate cancer	0.000998	0.00177	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—TBXAS1—prostate cancer	0.000995	0.00229	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTA4—prostate cancer	0.000995	0.00229	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NPPA—prostate cancer	0.000984	0.00226	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HIST1H4H—prostate cancer	0.000984	0.00226	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	0.000972	0.00223	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTA2—prostate cancer	0.00097	0.00223	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Docetaxel—prostate cancer	0.000969	0.00172	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ABCG5—prostate cancer	0.000958	0.0022	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SULT1A1—prostate cancer	0.000958	0.0022	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Docetaxel—prostate cancer	0.000957	0.00169	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Docetaxel—prostate cancer	0.00095	0.00168	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Etoposide—prostate cancer	0.00095	0.00168	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Docetaxel—prostate cancer	0.000949	0.00168	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Mitoxantrone—prostate cancer	0.000946	0.00167	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Capecitabine—prostate cancer	0.000938	0.00166	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTA1—prostate cancer	0.000935	0.00215	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Prednisone—prostate cancer	0.000931	0.00165	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Capecitabine—prostate cancer	0.000927	0.00164	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NAT2—prostate cancer	0.000925	0.00213	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HSD3B2—prostate cancer	0.000925	0.00213	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTO1—prostate cancer	0.000925	0.00213	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Capecitabine—prostate cancer	0.00092	0.00163	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Capecitabine—prostate cancer	0.000919	0.00163	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Epirubicin—prostate cancer	0.00091	0.00161	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PENK—prostate cancer	0.00091	0.00209	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Etoposide—prostate cancer	0.000906	0.0016	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Docetaxel—prostate cancer	0.0009	0.00159	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Epirubicin—prostate cancer	0.000896	0.00159	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	0.000889	0.00204	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP2C18—prostate cancer	0.000887	0.00204	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PLCB2—prostate cancer	0.000887	0.00204	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—LRP2—prostate cancer	0.000887	0.00204	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Etoposide—prostate cancer	0.000876	0.00155	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Capecitabine—prostate cancer	0.000872	0.00154	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Docetaxel—prostate cancer	0.00087	0.00154	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—P4HB—prostate cancer	0.00087	0.002	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GHR—prostate cancer	0.000868	0.00199	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC22A1—prostate cancer	0.000846	0.00194	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Capecitabine—prostate cancer	0.000843	0.00149	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Etoposide—prostate cancer	0.000842	0.00149	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Doxorubicin—prostate cancer	0.000842	0.00149	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—B2M—prostate cancer	0.000837	0.00192	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TGFBR1—prostate cancer	0.000837	0.00192	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	0.000836	0.00192	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Prednisone—prostate cancer	0.000836	0.00148	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Etoposide—prostate cancer	0.000835	0.00148	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Etoposide—prostate cancer	0.000834	0.00148	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NRP1—prostate cancer	0.000832	0.00191	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Etoposide—prostate cancer	0.00083	0.00147	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Doxorubicin—prostate cancer	0.00083	0.00147	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Prednisone—prostate cancer	0.000825	0.00146	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SULT2A1—prostate cancer	0.000824	0.00189	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—RPS19—prostate cancer	0.000823	0.00189	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKR1C3—prostate cancer	0.000823	0.00189	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PRKACB—prostate cancer	0.000819	0.00188	CbGpPWpGaD
Glycerol Phenylbutyrate—Fatigue—Prednisone—prostate cancer	0.000819	0.00145	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—MED12—prostate cancer	0.000811	0.00186	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GNG5—prostate cancer	0.000805	0.00185	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PPP3CA—prostate cancer	0.000799	0.00183	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Docetaxel—prostate cancer	0.00079	0.0014	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Etoposide—prostate cancer	0.000787	0.00139	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Prednisone—prostate cancer	0.000776	0.00137	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NCOA3—prostate cancer	0.000775	0.00178	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—VIP—prostate cancer	0.000773	0.00178	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GNRH1—prostate cancer	0.000773	0.00178	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PRKCZ—prostate cancer	0.000772	0.00177	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Capecitabine—prostate cancer	0.000765	0.00135	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	0.000762	0.00175	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CALR—prostate cancer	0.000759	0.00174	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Docetaxel—prostate cancer	0.000753	0.00133	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Prednisone—prostate cancer	0.000751	0.00133	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GRP—prostate cancer	0.000749	0.00172	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LPAR1—prostate cancer	0.000749	0.00172	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—FGFR4—prostate cancer	0.000746	0.00171	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PARP1—prostate cancer	0.000746	0.00171	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PLCB2—prostate cancer	0.000742	0.0017	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LRP2—prostate cancer	0.000742	0.0017	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HPGDS—prostate cancer	0.000739	0.0017	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CALCA—prostate cancer	0.000737	0.00169	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP2C19—prostate cancer	0.000735	0.00169	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Capecitabine—prostate cancer	0.000729	0.00129	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Epirubicin—prostate cancer	0.000728	0.00129	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Docetaxel—prostate cancer	0.000728	0.00129	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—P4HB—prostate cancer	0.000727	0.00167	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CX3CL1—prostate cancer	0.000727	0.00167	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTT1—prostate cancer	0.000717	0.00165	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ACHE—prostate cancer	0.000717	0.00165	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HIST1H2BG—prostate cancer	0.000714	0.00164	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP2A6—prostate cancer	0.000709	0.00163	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PDE4D—prostate cancer	0.000707	0.00163	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GRB7—prostate cancer	0.000707	0.00163	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HSPA1A—prostate cancer	0.000707	0.00162	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	0.000706	0.00162	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Capecitabine—prostate cancer	0.000705	0.00125	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Docetaxel—prostate cancer	0.0007	0.00124	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Docetaxel—prostate cancer	0.000694	0.00123	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Docetaxel—prostate cancer	0.000693	0.00123	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AKR1C3—prostate cancer	0.00069	0.00158	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Docetaxel—prostate cancer	0.00069	0.00122	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HIST1H4H—prostate cancer	0.000689	0.00158	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PRKACB—prostate cancer	0.000686	0.00158	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Prednisone—prostate cancer	0.000681	0.00121	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP17A1—prostate cancer	0.000679	0.00156	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CASP9—prostate cancer	0.000678	0.00156	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Capecitabine—prostate cancer	0.000678	0.0012	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Doxorubicin—prostate cancer	0.000674	0.00119	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GNG5—prostate cancer	0.000673	0.00155	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Capecitabine—prostate cancer	0.000672	0.00119	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Capecitabine—prostate cancer	0.000671	0.00119	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	0.00067	0.00154	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Capecitabine—prostate cancer	0.000668	0.00118	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—PRKCQ—prostate cancer	0.000657	0.00151	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Docetaxel—prostate cancer	0.000654	0.00116	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Epirubicin—prostate cancer	0.000654	0.00116	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Prednisone—prostate cancer	0.00065	0.00115	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NCOA2—prostate cancer	0.000647	0.00149	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Epirubicin—prostate cancer	0.000645	0.00114	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000641	0.00114	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Epirubicin—prostate cancer	0.00064	0.00113	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Capecitabine—prostate cancer	0.000633	0.00112	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Prednisone—prostate cancer	0.000628	0.00111	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—FGF10—prostate cancer	0.000624	0.00143	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC5A5—prostate cancer	0.000617	0.00142	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Epirubicin—prostate cancer	0.000607	0.00108	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Doxorubicin—prostate cancer	0.000605	0.00107	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Prednisone—prostate cancer	0.000604	0.00107	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP2E1—prostate cancer	0.000603	0.00139	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Prednisone—prostate cancer	0.000599	0.00106	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Prednisone—prostate cancer	0.000598	0.00106	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Doxorubicin—prostate cancer	0.000597	0.00106	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NQO1—prostate cancer	0.000596	0.00137	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Prednisone—prostate cancer	0.000595	0.00105	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—TGFBR2—prostate cancer	0.000594	0.00136	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000593	0.00105	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Doxorubicin—prostate cancer	0.000592	0.00105	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—TH—prostate cancer	0.000587	0.00135	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Epirubicin—prostate cancer	0.000587	0.00104	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTHLH—prostate cancer	0.000586	0.00135	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TGFBR1—prostate cancer	0.000586	0.00135	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—ITPR1—prostate cancer	0.000584	0.00134	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	0.000584	0.00134	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP3A4—prostate cancer	0.000581	0.00134	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	0.000578	0.00133	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKR1C3—prostate cancer	0.000577	0.00132	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PRKACB—prostate cancer	0.000574	0.00132	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP1B1—prostate cancer	0.000571	0.00131	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Prednisone—prostate cancer	0.000564	0.000998	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000562	0.000995	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PPP3CA—prostate cancer	0.000559	0.00128	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—THBS1—prostate cancer	0.000559	0.00128	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GGT1—prostate cancer	0.000553	0.00127	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ANXA1—prostate cancer	0.000551	0.00127	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NCOA1—prostate cancer	0.000545	0.00125	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Doxorubicin—prostate cancer	0.000543	0.000962	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PRKCZ—prostate cancer	0.000541	0.00124	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP19A1—prostate cancer	0.000537	0.00123	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—LPL—prostate cancer	0.000535	0.00123	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Epirubicin—prostate cancer	0.000533	0.000943	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—PDGFRB—prostate cancer	0.000531	0.00122	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PARP1—prostate cancer	0.000522	0.0012	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGFR4—prostate cancer	0.000522	0.0012	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—RXRA—prostate cancer	0.000519	0.00119	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CALCA—prostate cancer	0.000516	0.00119	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—ERCC2—prostate cancer	0.000513	0.00118	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Epirubicin—prostate cancer	0.000508	0.0009	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	0.000504	0.00116	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCL12—prostate cancer	0.000504	0.00116	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—ERBB3—prostate cancer	0.000502	0.00115	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—FGFR2—prostate cancer	0.000501	0.00115	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—COMT—prostate cancer	0.000499	0.00115	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTP1—prostate cancer	0.000497	0.00114	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Doxorubicin—prostate cancer	0.000493	0.000873	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Epirubicin—prostate cancer	0.000491	0.000869	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ITPR1—prostate cancer	0.000489	0.00112	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MTHFR—prostate cancer	0.000482	0.00111	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—EP300—prostate cancer	0.000481	0.00111	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TERT—prostate cancer	0.000481	0.0011	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CASP9—prostate cancer	0.000475	0.00109	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Epirubicin—prostate cancer	0.000472	0.000836	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Doxorubicin—prostate cancer	0.00047	0.000832	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Epirubicin—prostate cancer	0.000468	0.000829	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Epirubicin—prostate cancer	0.000468	0.000828	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Epirubicin—prostate cancer	0.000465	0.000824	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—TYMS—prostate cancer	0.000462	0.00106	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NGFR—prostate cancer	0.00046	0.00106	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PRKCQ—prostate cancer	0.00046	0.00106	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HIF1A—prostate cancer	0.00046	0.00106	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTM1—prostate cancer	0.000457	0.00105	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MAP3K7—prostate cancer	0.000455	0.00104	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Doxorubicin—prostate cancer	0.000454	0.000804	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—LPL—prostate cancer	0.000448	0.00103	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CAV1—prostate cancer	0.000445	0.00102	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Epirubicin—prostate cancer	0.000441	0.000781	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGF10—prostate cancer	0.000437	0.001	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Doxorubicin—prostate cancer	0.000437	0.000773	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Doxorubicin—prostate cancer	0.000433	0.000767	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP1A1—prostate cancer	0.000433	0.000995	CbGpPWpGaD
Glycerol Phenylbutyrate—Dermatitis—Doxorubicin—prostate cancer	0.000433	0.000766	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ADRB2—prostate cancer	0.000432	0.000994	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Doxorubicin—prostate cancer	0.00043	0.000762	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ERCC2—prostate cancer	0.00043	0.000987	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—VAV3—prostate cancer	0.000422	0.000969	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—BAD—prostate cancer	0.000418	0.000961	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TGFBR2—prostate cancer	0.000416	0.000955	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ITPR1—prostate cancer	0.000409	0.00094	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Doxorubicin—prostate cancer	0.000408	0.000723	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—APC—prostate cancer	0.000405	0.000931	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—MTHFR—prostate cancer	0.000404	0.000928	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—EGF—prostate cancer	0.0004	0.00092	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IRS1—prostate cancer	0.0004	0.00092	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PPARA—prostate cancer	0.000396	0.00091	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IGF1R—prostate cancer	0.000391	0.000899	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—GSK3B—prostate cancer	0.000389	0.000893	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—INS—prostate cancer	0.000383	0.000881	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CREBBP—prostate cancer	0.000376	0.000863	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LPL—prostate cancer	0.000375	0.000862	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CAV1—prostate cancer	0.000372	0.000856	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PDGFRB—prostate cancer	0.000372	0.000854	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ITGB3—prostate cancer	0.000362	0.000832	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MAP2K1—prostate cancer	0.000358	0.000824	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CD—prostate cancer	0.000356	0.000818	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	0.000356	0.000817	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SERPINE1—prostate cancer	0.000352	0.000809	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ERBB3—prostate cancer	0.000351	0.000807	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGFR2—prostate cancer	0.000351	0.000806	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—FGF2—prostate cancer	0.000341	0.000783	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CG—prostate cancer	0.000339	0.000779	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TERT—prostate cancer	0.000337	0.000774	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NOS3—prostate cancer	0.000336	0.000773	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—JAK2—prostate cancer	0.000327	0.000751	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HIF1A—prostate cancer	0.000322	0.00074	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—INS—prostate cancer	0.000321	0.000738	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MDM2—prostate cancer	0.000319	0.000733	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CREBBP—prostate cancer	0.000315	0.000723	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—ERBB2—prostate cancer	0.000315	0.000723	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LEP—prostate cancer	0.000314	0.000722	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CAV1—prostate cancer	0.000311	0.000715	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CB—prostate cancer	0.00031	0.000713	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—KDR—prostate cancer	0.000308	0.000707	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PTGS2—prostate cancer	0.000308	0.000707	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ESR1—prostate cancer	0.0003	0.000689	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CD—prostate cancer	0.000298	0.000685	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—BAD—prostate cancer	0.000293	0.000673	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CDKN1B—prostate cancer	0.000291	0.000669	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APC—prostate cancer	0.000284	0.000652	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CG—prostate cancer	0.000284	0.000652	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NOS3—prostate cancer	0.000282	0.000647	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IRS1—prostate cancer	0.00028	0.000644	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EGF—prostate cancer	0.00028	0.000644	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CTNNB1—prostate cancer	0.000275	0.000632	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GSK3B—prostate cancer	0.000272	0.000625	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CDKN1A—prostate cancer	0.000269	0.000618	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—INS—prostate cancer	0.000269	0.000617	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PTEN—prostate cancer	0.000268	0.000616	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CREBBP—prostate cancer	0.000263	0.000604	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CB—prostate cancer	0.00026	0.000597	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IGF1—prostate cancer	0.00026	0.000597	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PTGS2—prostate cancer	0.000258	0.000592	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—EP300—prostate cancer	0.000256	0.000588	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MAP2K1—prostate cancer	0.000251	0.000577	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CD—prostate cancer	0.000249	0.000573	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SRC—prostate cancer	0.000249	0.000571	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SERPINE1—prostate cancer	0.000247	0.000567	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—STAT3—prostate cancer	0.00024	0.000551	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGF2—prostate cancer	0.000239	0.000549	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NOS3—prostate cancer	0.000235	0.000541	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—JAK2—prostate cancer	0.000229	0.000526	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PTEN—prostate cancer	0.000225	0.000516	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MDM2—prostate cancer	0.000223	0.000513	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MYC—prostate cancer	0.000223	0.000512	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TGFB1—prostate cancer	0.000222	0.000511	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ERBB2—prostate cancer	0.00022	0.000506	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—EGFR—prostate cancer	0.000218	0.000501	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CB—prostate cancer	0.000217	0.000499	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—EP300—prostate cancer	0.000214	0.000492	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCL8—prostate cancer	0.000209	0.00048	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—KRAS—prostate cancer	0.000206	0.000473	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CDKN1B—prostate cancer	0.000204	0.000469	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CASP3—prostate cancer	0.0002	0.000459	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL2—prostate cancer	0.0002	0.000459	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCND1—prostate cancer	0.000195	0.000447	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CTNNB1—prostate cancer	0.000193	0.000443	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CA—prostate cancer	0.000189	0.000435	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MMP9—prostate cancer	0.000189	0.000434	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CDKN1A—prostate cancer	0.000188	0.000432	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTEN—prostate cancer	0.000188	0.000432	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EP300—prostate cancer	0.000179	0.000412	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SRC—prostate cancer	0.000174	0.0004	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—VEGFA—prostate cancer	0.00017	0.00039	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—STAT3—prostate cancer	0.000168	0.000386	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IL6—prostate cancer	0.000168	0.000385	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CA—prostate cancer	0.000158	0.000364	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MYC—prostate cancer	0.000156	0.000359	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TGFB1—prostate cancer	0.000156	0.000358	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKT1—prostate cancer	0.000155	0.000355	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EGFR—prostate cancer	0.000153	0.000351	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—KRAS—prostate cancer	0.000144	0.000331	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CA—prostate cancer	0.000132	0.000304	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AKT1—prostate cancer	0.000129	0.000297	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TP53—prostate cancer	0.000128	0.000295	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL6—prostate cancer	0.000117	0.00027	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKT1—prostate cancer	0.000108	0.000249	CbGpPWpGaD
